Solvent and salting effects on sample preparation for the determination of fenofibric acid in human plasma by HPLC-DAD

Microchemical Journal

Volumn 75, Issue 3, 2003, Pages 179-187

  Lovin, Ionel ^a   Albu, Florin ^a   Tache, Florentin ^b   David, Victor ^b   Medvedovici, Andrei ^a  

^a LaborMed Pharma SA   (Romania)

^b UNIVERSITY OF BUCHAREST   (Romania)

Author keywords

Deproteinization; Fenofibrate; Fenofibric acid; HPLC DAD; Human plasma; Salting effects

Indexed keywords

BENZENE DERIVATIVE; FENOFIBRATE; FENOFIBRIC ACID; PHOSPHORIC ACID; SILICON DERIVATIVE; SODIUM CHLORIDE; SOLVENT;

ARTICLE; BIOEQUIVALENCE; BLOOD SAMPLING; DRUG FORMULATION; ELUTION; FLOW RATE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; PHASE TRANSITION; POROSITY; QUANTITATIVE ANALYSIS; RADIATION DETECTION; ULTRAVIOLET RADIATION;

EID: 0242384178     PISSN: 0026265X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0026-265X(03)00093-6     Document Type: Article

References (15)

1. Caldwell J., Strolin-Benedetti M., Weil A. Arzneim. Forsch. 26:1976;896.
2. Rossner S., Oro L. Atherosclerosis. 38:1981;273.
3. Mainguy Y., Vidal R., Strolin-Benedetti M. J. Pharm. Clin. 4:1985;59.
4. Williams F.M. Clin. Pharmacokin. 10:1985;392.
5. Benedetti S., Guichard M., Vidal J.P., Donath R. Acta Pharmacol. Toxicol. 59:1986;167.
6. Cotta-Ramusino A., Carozzi A. J. Chromatogr. Biomed. Appl. 56:1986;419.
7. Streel B., Hubert Ph., Ceccato A. J. Chromatogr. B. 742:2000;391.
8. Loessner A., Banditt P., Troeger U. Pharmazie. 56:2001;50.
9. Guichard J.P., Sauron L.P. Cur. Ther. Res. 54:1993;610.
10. Masnatta L.C., Cuniberti L.A., Rey R.H., Werba J.P. J. Chromatogr. B. 687:1996;437.
11. Nikitas P., Pappa-Lousi A., Agrafiotou P. J. Chromatogr. A. 946:2002;33.
12. Vervoort R.J.M., Debets A.J.J., Claessens H.A., Cramers C.A., Jong G.J. J. Chromatogr. A. 897:2000;1.
13. Meylan W.M., Howard P.H. J. Pharm. Sci. 84:1995;83.
14. Hansch C., Anderson S.M. J. Org. Chem. 32:1967;2583.
15. Ermer J. J. Pharm. Biomed. Anal. 24:2001;755.